Results 21 to 30 of about 478,042 (312)

An overview and a roadmap for artificial intelligence in hematology and oncology

Journal of Cancer Research and Clinical Oncology, 2023
Artificial intelligence (AI) is influencing our society on many levels and has broad implications for the future practice of hematology and oncology. However, for many medical professionals and researchers, it often remains unclear what AI can and cannot
Wiebke Rösler, M. Altenbuchinger, B. Baessler, T. Beissbarth, G. Beutel, R. Bock, N. von Bubnoff, Jan-Niklas Eckardt, S. Foersch, C. Loeffler, J. Middeke, Martha Mueller, T. Oellerich, Benjamin Risse, A. Scherag, C. Schliemann, M. Scholz, R. Spang, C. Thielscher, I. Tsoukakis, Jakob Nikolas Kather   +20 more
semanticscholar   +1 more source

American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

Blood Advances, 2020
BACKGROUND Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease (SCD), but pose significant clinical challenges. Guidance for specific indications and administration of transfusion, as well as screening, prevention ...
S. Chou, Mouaz Alsawas, R. Fasano, Joshua J Field, J. Hendrickson, J. Howard, Michelle Kameka, J. Kwiatkowski, F. Pirenne, Patricia A. Shi, S. Stowell, S. Thein, C. Westhoff, Trisha E. Wong, E. Akl   +14 more
semanticscholar   +1 more source

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

Journal of Hematology & Oncology, 2021
The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH) on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation (allo-HSCT) facilitated the standardization of clinical ...
Xiao-hui Zhang, Jing Chen, Mingzhe Han, He Huang, E. Jiang, M. Jiang, Y. Lai, Daihong Liu, Qi-fa Liu, Ting Liu, H. Ren, Yong-Ping Song, Zi-min Sun, Xiaowen Tang, Jian-min Wang, De-Pei Wu, Lan-ping Xu, Xi Zhang, Dao-bin Zhou, Xiao-jun Huang   +19 more
semanticscholar   +1 more source

American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

Blood Advances, 2020
BACKGROUND Central nervous system (CNS) complications are among the most common, devastating sequelae of sickle cell disease (SCD) occurring throughout the lifespan.
M. DeBaun, L. Jordan, A. A. King, J. Schatz, E. Vichinsky, C. Fox, R. McKinstry, P. Telfer, M. Kraut, L. Daraz, F. Kirkham, M. Murad   +11 more
semanticscholar   +1 more source

American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Blood Advances, 2020
BACKGROUND The management of acute and chronic pain for individuals living with sickle cell disease (SCD) is a clinical challenge. This reflects the paucity of clinical SCD pain research and limited understanding of the complex biological differences ...
A. Brandow, C. P. Carroll, Susan E. Creary, Ronisha Edwards-Elliott, J. Glassberg, R. Hurley, A. Kutlar, Mohamed Seisa, J. Stinson, J. Strouse, F. Yusuf, W. Zempsky, E. Lang   +12 more
semanticscholar   +1 more source

Next generations of CAR-T cells - new therapeutic opportunities in hematology?

Frontiers in Immunology, 2022
In recent years, the introduction of chimeric antigen receptor (CAR) T-cell therapies into clinics has been a breakthrough in treating relapsed or refractory malignancies in hematology and oncology.
Jaromir Tomasik, M. Jasiński, G. Basak
semanticscholar   +1 more source

Hematology Reference Intervals for Holstein Cows in Southern China: A Study of 786 Subjects

Veterinary Sciences, 2022
Hematology RIs help clinicians and researchers determine whether a hematology parameter is abnormal, which plays an important role in animal health surveillance.
Hongbo Chen, Bo Yu, Chenhui Liu, Lei Cheng, Jie Yu, Xiuzhong Hu, Min Xiang   +6 more
doaj   +1 more source

American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Blood Advances, 2019
BACKGROUND Despite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist physicians with the management of patients. OBJECTIVE These evidence-based
C. Neunert, Deirdra R. Terrell, D. Arnold, G. Buchanan, D. Cines, N. Cooper, A. Cuker, J. Despotovic, J. George, R. Grace, T. Kühne, D. Kuter, W. Lim, K. McCrae, Barbara Pruitt, Hayley Shimanek, S. Vesely   +16 more
semanticscholar   +1 more source

Preanalytical Errors in a Hematology Laboratory: An Experience from a Tertiary Care Center

Diagnostics, 2023
Background: Laboratory errors arise at any stage of testing. Detecting these inaccuracies before results are revealed might delay diagnosis and treatment, causing patient distress.
M. Iqbal, Aisha Tabassum, A. Arbaeen, A. Qasem, Adel G Elshemi, H. Almasmoum   +5 more
semanticscholar   +1 more source

Hematology profile analysis in coronavirus disease 2019 (COVID-19) patients

Advances in Laboratory Medicine, 2022
Some hematological parameters were reported as markers to assess severity of COVID-19 patients. Comorbidities were risk factors for severe COVID-19. Differences in hematology profile based on severity and comorbidity, and correlation between hematology ...
Setio Felisia, Muhadi Darwati, Nurulita Asvin, Arif Mansyur, Djaharuddin Irawaty, Seweng Arifin   +5 more
doaj   +1 more source